Monthly Archives: July 2012

LYSOGENE ANNOUNCES COMPLETE ENROLLMENT IN ITS SAF-301 PHASE I/II CLINICAL TRIAL OF INTRACEREBRAL GENE THERAPY IN CHILDREN WITH SANFILIPPO TYPE A SYNDROME.